Your browser doesn't support javascript.
loading
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
Stein, Alexander; Paschold, Lisa; Tintelnot, Joseph; Goekkurt, Eray; Henkes, Svenja-Sibylla; Simnica, Donjete; Schultheiss, Christoph; Willscher, Edith; Bauer, Marcus; Wickenhauser, Claudia; Thuss-Patience, Peter; Lorenzen, Sylvie; Ettrich, Thomas; Riera-Knorrenschild, Jorge; Jacobasch, Lutz; Kretzschmar, Albrecht; Kubicka, Stefan; Al-Batran, Salah-Eddin; Reinacher-Schick, Anke; Pink, Daniel; Sinn, Marianne; Lindig, Udo; Hiegl, Wolfgang; Hinke, Axel; Hegewisch-Becker, Susanna; Binder, Mascha.
Afiliação
  • Stein A; Hematology-Oncology Practice Eppendorf (HOPE), Hamburg, Germany.
  • Paschold L; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tintelnot J; Department of Internal Medicine IV-Oncology/Hematology, University Hospital, Martin-Luther University, Halle, Germany.
  • Goekkurt E; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Henkes SS; Hematology-Oncology Practice Eppendorf (HOPE), Hamburg, Germany.
  • Simnica D; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schultheiss C; Department of Internal Medicine IV-Oncology/Hematology, University Hospital, Martin-Luther University, Halle, Germany.
  • Willscher E; Department of Internal Medicine IV-Oncology/Hematology, University Hospital, Martin-Luther University, Halle, Germany.
  • Bauer M; Department of Internal Medicine IV-Oncology/Hematology, University Hospital, Martin-Luther University, Halle, Germany.
  • Wickenhauser C; Department of Internal Medicine IV-Oncology/Hematology, University Hospital, Martin-Luther University, Halle, Germany.
  • Thuss-Patience P; Institute of Pathology, University Hospital, Martin-Luther University, Halle, Germany.
  • Lorenzen S; Institute of Pathology, University Hospital, Martin-Luther University, Halle, Germany.
  • Ettrich T; Charité-University Medicine Berlin, Berlin, Germany.
  • Riera-Knorrenschild J; Rechts der Isar Hospital, Technical University of Munich, Munich, Germany.
  • Jacobasch L; University Hospital Ulm, Ulm, Germany.
  • Kretzschmar A; University Hospital, Philipps-Universität Marburg, Germany.
  • Kubicka S; Practice for Hematology-Oncology, Dresden, Germany.
  • Al-Batran SE; MVZ-Mitte, Leipzig, Germany.
  • Reinacher-Schick A; Kreisklinik Reutlingen, Reutlingen, Germany.
  • Pink D; Institute of Clinical Cancer Research, Krankenhaus Nordwest, Frankfurt, Germany.
  • Sinn M; St Josef-Hospital Bochum, University of Bochum, Germany.
  • Lindig U; Klinik und Poliklinik für Innere Medizin C, University Greifswald, Greifswald, Germany.
  • Hiegl W; Klinik für Hämatologie, Onkologie und Palliativmedizin, Sarkomzentrum Berlin-Brandenburg, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany.
  • Hinke A; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hegewisch-Becker S; University Hospital, Jena, Germany.
  • Binder M; AIO Studien gGmbH Berlin, Germany.
JAMA Oncol ; 8(8): 1150-1158, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35737383
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Nivolumabe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Nivolumabe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha